Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High 
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India 
Puma’s Historic Rivalry With Adidas Enters a New Era as Anta Deal Signals Turnaround Push 
Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday 
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook 
Microsoft AI Spending Surge Sparks Investor Jitters Despite Solid Azure Growth 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless 
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics 
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
The Maire - EuroChem Case: Three Lessons for Global Business 
DENVER, May 24, 2017 -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf, President and Chief Executive Officer, and Stephen M. Deitsch, Senior Vice President, Chief Financial Officer and Treasurer will present at the Jefferies 2017 Global Healthcare Conference on Wednesday, June 7, 2017, at 4:00 p.m. EDT.
A live webcast of the presentation and copies of the materials presented can be accessed via BioScrip’s Investor Relations website at https://www.bioscrip.com/investors or through the following link http://wsw.com/webcast/jeff105/bios.
About BioScrip
BioScrip, Inc. is a leading national provider of infusion and home care management solutions. BioScrip partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.
Investor Contacts: Stephen Deitsch Chief Financial Officer & Treasurer T: (720) 697-5200 [email protected] David Clair ICR, Inc. T: (646) 277-1266 [email protected]
